Jazz Pharmaceuticals (JAZZ) Inventory (2010 - 2026)

Jazz Pharmaceuticals' Inventory history runs 17 years deep, the most recent figure standing at $437.5 million for Q1 2026.

• In Q1 2026, Inventory fell 11.22% year-over-year to $437.5 million; the TTM figure through Mar 2026 stood at $437.5 million (down 11.22% YoY), while the FY2025 annual figure was $417.0 million, down 13.21% from the prior year.
• Inventory was $437.5 million for Q1 2026 at Jazz Pharmaceuticals, up from $417.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $985.5 million in Q1 2022 to a low of $417.0 million in Q4 2025.
• Historically, Inventory has averaged $606.2 million across 5 years, with a median of $577.3 million in 2024.
• Biggest YoY gain for Inventory was 753.39% in 2022; the steepest drop was 36.01% in 2022.
• A 5-year view of Inventory shows it stood at $714.1 million in 2022, then dropped by 16.39% to $597.0 million in 2023, then slipped by 19.53% to $480.4 million in 2024, then dropped by 13.21% to $417.0 million in 2025, then climbed by 4.92% to $437.5 million in 2026.
• The last three Inventory figures came in at $437.5 million (Q1 2026), $417.0 million (Q4 2025), and $483.1 million (Q3 2025), per Business Quant data.